No. | Author, year | Study area (years of the survey) | Participants | Age range | Age groups (n) | Blood storage for PCR | DNA extraction | Investigated gene | PCR method | Malaria positive by PCR | Mixed infection (dual infection) | Mixed infection (Triple infection) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Asua et al. [2] | Uganda | Malaria positive (499) | 6 months to 10 years | Dried blood spots | Chelex extraction kits | 18S rRNA | Nested PCR | 474 | Pf/Pm (19) Pf/Po (14) Pf/Pv (3) Pm/Pv (1) Total = 37 | Pf/Pm/Po (1) | |
2. | Barber et al. [3] | Malaysia (2009–2011) | Malaria positive (653) | P. knowlesi (IQR 20–50 years), P. falciparum (IQR 9–31 years), P. vivax (19 years, IQR 7–32 years) | Triple infection: < 5 (1), 10–14 (1), 30–34 (1), 80–84 (1) Dual infection: < 5 (1), 5–9 (2), 10–14 (5), 15–19 (3), 20–24 (2), 25–29 (2), 30–34 (4), 35–39 (3), 40–44 (5), 45–49 (2), 50–54 (2), 70–74 (2), 75–79 (1) | NA | NA | 18S rRNA | Nested PCR | 445 | Pv/Pk (36) Pf/Pk (6) Pm/Pk (1) Pf/Pm (1) Total = 44 | Pf/Pv/Pk (2) Pv/Pm/Pk (2) |
3. | Calderaro et al. [4] | Italy (2000–2007) | Febrile patients (701) | NA | EDTA blood | High Pure Template Preparation kit (Roche Diagnostics, Mannheim, Germany) | 18S rRNA | Nested PCR | 159 | Pf/Po (3) Pf/Pm (1) Total = 4 | Pf/Pm/Po (2) | |
4. | Camargo-Ayala et al. [5] | Colombia (2012–2015) | Febrile patients (671) | < 5, 5–18, 18–60, and > 60 years | Triple infection: < 5 (4), 5–18 (2), 18–60 (6), > 60 (2) Dual infection: < 5 (16), 5–18 (56), 18–60 (139), > 60 (15) | EDTA blood | Pure Link Genomic DNA mini kit (Invitrogen) | 18S rRNA | Nested PCR | 531 | Pv/Pm (190) Pf/Pv (25) Pf/Pm (10) Total = 225 | Pf/Pm/Pv (14) |
5. | Dhangadamajhi et al. [6] | India (2008) | Febrile and asymptomatic (242) | 0–5 years, 6–15, and > 15 years | Triple infection: 0–5 (1), 6–15 (2), > 15 (2) Dual infection: 0–5 (7), 6–15 (32), > 15 (39) | EDTA blood | Phenol–Chloroform extraction | 18S rRNA | Nested PCR | 197 | Pf/Pv (15) Pf/Pm (54) Pv/Pm (10) Total = 79 | Pf/Pm/Pv (5) |
6. | Dormond et al. [40] | Switzerland (2004–2008) | Malaria positive (89) | >16 years | EDTA blood | MagNA Pure LC DNA isolation kit (Roche, Basel, Switzerland) | 18S rRNA | Nested PCR | 89 | Pf/Po (3) Pf/Pm (2) Total = 5 | Pf/Pm/Po (1) | |
7. | Fuehrer et al. [41] | Bangladesh: Chittagong Hill Tracts (2007–2008) Malaria Research Initiative Bandarban field site (2008–2009) | Febrile patients (379) | Any age | Dried blood spots | Modified Chelex-based technique, the InstaGene Whole Blood Kit (Bio-Rad Laboratories, Hercules, CA) | 18S rRNA | Nested PCR | 189 | Pf/Pv (21) Pf/Pm (2) Total = 23 | Pf/Pm/Pv (2) | |
8. | Gabrielli et al. [42] | Congo (2014) | Residents (306) | 1 week to < 5 years | Dried blood spots | The commercial kit Dried Blood spot DNA isolation Kit (Norgen Biotek Corp, Ontario, Canada) | 18S rRNA | Nested PCR | 164 | Pf/Pm (13) Pf/Po (2) Pf/Pv (1) Total = 16 | Pf/Pm/Pv (1) | |
9. | Hopkins et al. [22] | Uganda (2010–2011) | Residents (272) | 5–81 years: 5–10, 11–20, and ≥ 21 years | EDTA blood | Phenol–Chloroform extraction | 18S rRNA | Nested PCR and qPCR | 199 | Pf/Pm (38) Pf/Po (8) Total = 46 | Pf/Pm/Po (10) | |
10. | Jiang et al. [43] | Myanmar (2008) | Malaria positive (146) | NA | Dried blood spots | Chelex extraction kits | 18S rRNA | Nested PCR | 146 | Pf/Pk (13) Pv/Pk (13) Pf/Pv (10) Total = 36 | Pf/Pv/Pk (2) | |
11. | Kasehagen et al. [11] | Papua New Guinea (2001–2003) | Residents (16,209) | < 2, 2.0–3.9, 4.0–6.9, 7.0–9.9, 10.0–19.9, 20.0–39.9, and ≥ 40 years | EDTA blood | QIAamp 96 DNA Blood Kit (QIAGEN, Valencia, CA) | 18S rRNA | LDR-FMA | 658 | Pf/Pv (72) Pf/Pm (32) Pf/Po (13) Pv/Pm (17) Pv/Po (9) Pm/Po (4) Total = 147 | Pf/Pm/Pv (28) Pf/Pv/Po (5) Pf/Pm/Po (4) Pv/Pm/Po (4) Pf/Pv/Pm/Po (11) | |
12. | Krishna et al. [18] | India (2015) | Doubtful microscopic (355) | ≤ 1, > 1–4, >4–8, > 8–14, and > 14 years | Dried blood spots | FavorPrep Genomic DNA Mini Kit (Favorgen Biotech Corp., Taiwan). | 18S rRNA | Nested PCR | 353 | Pf/Pv (59) Pf/Pm (3) Total = 62 | Pf/Pm/Pv (5) Pf/Pv/Po (1) Pf/Pv/Pm/Po (1) | |
13. | Lorenzetti et al. [44] | Brazil (2003–2005) | Malaria positive (115) | 18–52 years | EDTA blood | Phenol–Chloroform extraction | 18S rRNA | Nested PCR | 115 | Pf/Pm (2) Pf/Pv (28) Total = 30 | Pf/Pm/Pv (1) | |
14. | Marques et al. [45] | Mozambique (2001–2002) | Residents (308) | 1–82 years | EDTA blood | Phenol–Chloroform extraction | 18S rRNA | Nested PCR | 115 | Pf/Pm (70) Pf/Po (10) Total = 80 | Pf/Pm/Po (9) | |
15. | May et al. [48] | Nigeria (1996–1997) | Residents (593) | Children in Abanla (1–11 years), Children in Ibadan (3–8 years), Children in health centres in Ibadan (0.8–11 years), Healthy adults (15–56 years) | EDTA blood | DNA-Easy Kit (Invitrogen, St. Louis, MO) | 18S rRNA | Nested PCR | 165 | Pf/Pm (41) Pf/Po (12) Total = 53 | Pf/Pm/Po (27) | |
16. | Mehlotra et al. [13] | Papua New Guinea (1998–1999) | Residents (1848) | All groups < 1–85 years: 2–4, 5–9, ≥ 10 years | Triple infection: 2–4 (2), 5–9 (8), ≥ 10 (24) Dual infection: 2–4 (14), 5–9 (51), ≥ 10 (115) | EDTA blood | QIAamp 96 spin blood kits (QIAGEN, Valencia, CA) | 18S rRNA | Nested PCR | 541 | Pf/Pv (116) Pf/Pm (27) Pf/Po (11) Pv/Pm (21) Pv/Po (4) Pm/Po (3) Total = 182 | Pf/Pm/Pv (23) Pf/Pv/Po (9) Pf/Pm/Po (1) Pf/Pv/Pm/Po (3) |
17. | Mehlotra et al. [12] | Papua New Guinea (1996) | Malaria positive (173) | 5–10 and > 11 years | Triple infection: 5–10 (1), > 11 (0) Dual infection: 5–10 (6), > 11 (9) | EDTA blood | QIAamp 96 or individual spin blood kits (QIAGEN, Valencia, CA) | 18S rRNA | Nested PCR | 163 | Pf/Pv (40) Pf/Pm (16) Pf/Po (4) Pv/Pm (3) Total = 63 | Pf/Pm/Pv (27) Pf/Pv/Po (8) Pf/Pm/Po (5) Pv/Pm/Po (1) Pf/Pv/Pm/Po (9) |
18. | Mueller et al. [14] | Papua New Guinea (2005) | Residents (2527) | < 10 and ≥ 20 years | EDTA blood | QIAmp 96 DNA Blood kits (Qiagen, CA) | 18S rRNA | A semi-quantitative post-PCR, ligase detection reaction/fluorescent microsphere assay (LDR-FMA) | 1844 | Pf/Pv (363) Pf/Pm (136) Pf/Po (27) Pv/Pm (26) Pv/Po (7) Pm/Po (1) Total = 560 | Pf/Pm/Pv (99) Pf/Pv/Po (33) Pf/Pm/Po (8) Pv/Pm/Po (6) Pf/Pv/Pm/Po (17) | |
19. | Nino et al. [46] | Colombia (2015–2016) | Febrile patients (1392) | NA | EDTA blood | Pure Link Genomic DNA mini kit (Invitrogen) | 18S rRNA | Nested PCR | 596 | Pf/Pv (111) Pv/Pm (340) Pf/Pm (29) Total = 480 | Pf/Pm/Pv (52) | |
20. | Pati et al. [19] | India | Febrile patients (1589) | Severe malaria (15–65 years) | Dried blood spots | Chelex extraction kits | 18S rRNA | Nested PCR | 110 | Pf/Pv (11) Pf/Pm (4) Pv/Pm (3) Total = 18 | Pf/Pm/Pv (5) | |
21. | Perandin et al. [20] | Italy | Febrile patients (122) | NA | EDTA blood | The High Pure PCR template preparation kit (Roche, Indianapolis, Ind.) | 18S rRNA | Nested PCR | 62 | Pf/Po (1) | Pf/Pm/Po (1) | |
22. | Peruzzi et al. [21] | Italy (2005–2006) | Febrile patients (139) | 2–49 years | Triple infection: 19 years | EDTA blood | High Pure PCR Template Preparation Kit” (Roche) | 18S rRNA | Nested PCR | 36 | None | Pf/Pm/Po (1) |
23. | Pongvongsa et al. [28] | Laos-Vietnam border (2010) | Residents (3059) Sample for PCR (135) | P. knowlesi (2–15 years) | Triple infection (Pf/Pv/Pk): mean 6.43 years (7) Dual infection (Pk/Pv): mean 7.4 years (5) | Dried blood spots | QIAamp DNA micro kit (QIAGEN, Tokyo, Japan) | 18S rRNA | Nested PCR | 90 | Pf/Pv (15) Pf/Pm (2 Pv/Pk (5) Total = 22 | Pf/Pm/Pv (1) Pf/Pv/Pk (7) |
24. | Putaporntip et al. [25] | Thailand (2006–2007) | Febrile patients (1874) | 1–81 years | Dried blood spots | Qiagen DNA Mini Kit | 18S rRNA | Nested PCR | 1751 | Pf/Pv (200) Pf/Pm (6) Pf/Po (2) Pf/Pk (5) Pv/Pm (8) Pv/Po (4) Pv/Pk (4) Pm/Po (1) Total = 230 | Pf/Pm/Pv (4) Pf/Pv/Po (7) Pf/Pv/Pm/Po (1) | |
25. | Rubio et al. [38] | Spain (1997–1998) | Febrile patients (168) | NA | EDTA blood | Modified Chelex-based technique, the InstaGene Whole Blood Kit (Bio-Rad Laboratories, Hercules, CA) | 18S rRNA | Nested PCR | 89 | Pf/Pm (4) Pf/Po (1) Pf/Pv (3) Total = 8 | Pf/Pm/Pv (1) | |
26. | Rubio et al. [39] | Equatorial Guinea (1996) | Febrile patients (159) | < 6 years | Dried blood spots | 5% Chelext-100 Resin (Bio-Rad Laboratories, Hercules, CA) | 18S rRNA | Nested PCR | 126 | Pf/Pm (36) Pf/Po (3) Pf/Pv (2) Total = 41 | Pf/Pv/Po (3) | |
27. | Sitali et al. [29] | Zambia (2012) | Residents (873) | < 6 years | Dried blood spots | Chelex extraction kits | 18S rRNA | Nested PCR | 474 | Pf/Pm (31) Pf/Po (10) Pf/Pv (1) Total = 42 | Pf/Pm/Po (6) Pf/Pm/Pv (1) | |
28. | Sluydts et al. [15] | Cambodia (2012) | Residents (5793) | 2–5, 5–14, 15–39, and ≥ 40 years | Dried blood spots | Instagene® Matrix resin (Bio-Rad, Singapore) | 18S rRNA | Two-step Real-time PCR | 368 | Pf/Pv (56) Pf/Pm (5) Pf/Po (1) Pv/Pm (3) Pv/Po (11) Total = 76 | Pf/Pm/Pv (4) Pf/Pv/Po (1) Pf/Pv/Pm/Po (1) | |
29. | Steenkeste et al. [16] | Cambodia (2001) | Residents (337) | NA | Dried blood spots | the Instagene resin (Bio-Rad, USA) | 18S rRNA | Nested PCR | 140 | Pf/Pv (52) Pf/Pm (15) Pf/Po (4) Total = 71 | Pf/Pv/Po (7) Pf/Pm/Pv (24) Pf/Pv/Pm/Po (8) | |
30. | Steenkeste et al. [17] | Cambodia (2001) | Residents (134) | < 1– > 60 years: < 1, 1, 2, 3, 4, 5–9, 10–14, 15–19, 20–39, 40–60, and > 60 years | Dried blood spots | Instagene resin (Bio-Rad, Germany) a | 18S rRNA | Nested PCR | 102 | Pf/Pm (4) Pf/Po (2) Pf/Pv (18) Pv/Pm (3) Total = 27 | Pf/Pm/Pv (7) Pf/Pv/Po (3) Pf/Pv/Pm/Po (3) | |
31. | Subissi et al. [23] | Uganda (2010) | Residents (509) | 1–5, 6–10, and > 20 years | Triple infection: 1–5 (5), 6–10 (5), > 20 (0) Dual infection: 1–5 (27), 6–10 (24), > 20 (2) | Dried blood spots | QIAamp mini kit (QIAGEN, Venlo, The Netherlands) | 18S rRNA | Nested PCR | 299 | Pf/Pm (39) Pf/Po (14) Total = 53 | Pf//Pm/Po (10) |
32. | Toma et al. [27] | Laos (1997) | Residents (336) | < 11– > 50 years: 2–68 years in Phavang and 0–75 years in Sisomsouen | EDTA blood | GFX Genomic Blood DNA Purification Kit (Pharmacia Biotech). | 18S rRNA | Nested PCR | 117 | Pf/Pv (19) Pf/Pm (2) Pv/Pm (2) Pv/Po (1) Total = 24 | Pf/Pm/Pv (1) Pf/Pv/Po (1) Pf/Pv/Pm/Po (1) | |
33. | Woldearegai et al. [47] | Gabon (2016) | Residents (834) | 1–96 years: 1–5, 6–10, 11–15, 16–20, 21–25, 26–30, 31–40, 41–50, 51–60, 61–70, 71–80, and 81–96 years | EDTA blood | QIAsymphony DSP DNA kit | 18S rRNA | Nested PCR | 618 | Pf/Pm (123) Pf/Po (43) Pm/Po (1) Total = 167 | Pf//Pm/Po (51) | |
34. | Zhou et al. [24] | Thailand (1995–1996) | Residents (548) | NA | Thick smear | 30% Chelex-100 | 18S rRNA | Nested PCR | 114 | Pf/Pv (10) Pf/Pm (6) Pv/Pm (19) Pv/Po (1) Total = 36 | Pf/Pm/Pv (49) Pf/Pv/Po (2) Pv/Pm/Po (1) Pf/Pv/Pm/Po (7) | |
35. | Zhou et al. [26] | China (2008–2012) | Febrile patients (562) | NA | Dried blood spots | QIAamp DNA Mini Kit (QIAGEN China (Shanghai) | 18S rRNA | Nested PCR | 384 | Pf/Pv (67) Pv/Po (2) Pf/Pk (2) Pf/Pm (2) Po/Pm (1) Total = 74 | Pf/Pv/Po (3) Pf/Pm/Pv (1) Pv/Pm/Po (1) Pf/Pv/Pm/Po (1) | |
Total = 12,023 | 2 species = 3059 Pf/Pv = 1318 Pf/Po = 188 Pf/Pm = 775 Pf/Pk = 26 Pv/Pm = 645 Pv/Po = 39 Pv/Pk = 58 Pm/Po = 10 Pm/Pk = 1 | 3 species = 601 Pf/Pm/Pv = 355 Pf/Pv/Po = 83 Pf/Pm/Po = 137 Pf/Pv/Pk = 11 Pv/Pm/Po = 13 Pv/Pm/Pk = 2 4 species = 53 |